| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |